"Global Infectious Disease Treatment Market 2014-2018" is now available at Fast Market Research

Infectious diseases can be caused by various pathogenic microorganisms such as bacteria, fungi, parasites, or viruses. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defence system or can directly target the causative agent.

TechNavio's analysts forecast the Global Infectious Disease Treatment market to grow at a CAGR of 3.43 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Infectious Disease Treatment market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of various drugs administered to treat various infectious diseases caused by bacteria, virus, fungi, and parasites, which include:

Full Report Details at
- http://www.fastmr.com/prod/878889_global_infectious_disease_treatment_market.aspx?afid=301

* Antibacterial drugs (beta-lactams, macrolides, aminoglycosides, phenicols, quinolones, sulfonamides, tetracyclines, and other antibacterials)
* Antiviral drugs (HIV, hepatitis C, hepatitis B, and other antivirals)
* Antifungal drugs (azoles, pyrimidines, echinodians, polyenes, allylamines, and other antifungal drugs)
* Antiparasitic drugs

TechNavio's report, the Global Infectious Disease Treatment Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Infectious Disease Treatment market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

* Americas
* APAC
* EMEA

Key Vendors

* F. Hoffmann-La Roche
* Gilead Sciences
* GlaxoSmithKline
* Johnson & Johnson
* Merck
* Pfizer

Other Prominent Vendors

* Achillion Pharmaceuticals
* AbbVie
* Astellas Pharma
* AstraZeneca
* Auritec Pharmaceuticals
* Bayer
* Bristol-Myers Squibb
* Chimerix Pharmaceuticals
* Cubist
* Eli Lilly
* Isis Pharmaceuticals
* Mitsubishi Tanabe Pharma
* Novartis
* pSivida
* Sanofi

Market Driver

* Launch of Direct Acting Antivirals
* For a full, detailed list, view our report

Market Challenge

* Generic Erosion
* For a full, detailed list, view our report

Market Trend

* Emergence of IFN-free Therapies
* For a full, detailed list, view our report

Key Questions Answered in this Report

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022
- Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management
- Animal/Veterinary Vaccines Market - Global Forecast to 2018
- Crohn's Disease Global Clinical Trials Review, H2, 2013
- Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies